What are the recommended acute and preventive treatment options for migraine in a 61-year-old woman?

Migraine Treatment for a 61-Year-Old Woman

For acute migraine treatment in a 61-year-old woman, start with NSAIDs (naproxen or ibuprofen 400mg) plus an antiemetic (metoclopramide or domperidone), and if this fails after three consecutive attacks, advance to triptans with careful cardiovascular screening, or preferentially use gepants (CGRP antagonists) which avoid cardiovascular concerns common in this age group 1, 2.

Acute Treatment Algorithm

First-Line Approach

• NSAIDs (naproxen or ibuprofen 400mg) combined with antiemetic (metoclopramide 10mg or domperidone) 1, 2
• Administer antiemetic 15-20 minutes before NSAID to address delayed gastric emptying common in older adults 3
• Aspirin-acetaminophen-caffeine combination is also effective 1

Second-Line: After Three Failed Attacks

The choice here requires careful consideration of cardiovascular risk:

If cardiovascular disease or risk factors present:

• Gepants (CGRP antagonists) are preferred - they lack vasoconstrictive properties and are safer in older adults 1, 3
• Ditans are an alternative option 1

If cardiovascular screening is negative:

• Triptans remain effective, but monitor blood pressure regularly 2, 4
• Despite theoretical concerns, robust evidence does not support increased cardiovascular events with triptan use in older adults when properly screened 2
• Avoid triptans entirely if she has coronary artery disease, stroke history, or peripheral arterial disease 4, 5

Severe Attacks

• Intravenous acetylsalicylic acid or subcutaneous sumatriptan (only if cardiovascular disease excluded) 6
• Intravenous magnesium, valproic acid, or metoclopramide in emergency settings 4

Preventive Treatment

If migraine adversely affects her ≥2 days per month despite optimized acute treatment, initiate preventive therapy 2.

First-Line Preventive Options

The 2024 VA/DoD guideline and recent evidence support multiple first-line choices 1:

• Beta-blockers: Propranolol or metoprolol (monitor for bradycardia, fatigue) 1, 2
• Topiramate: Effective but watch for cognitive side effects, particularly problematic in older adults 1, 2
• Candesartan (angiotensin-receptor blocker): Excellent choice if she has hypertension 1, 2
• Lisinopril: Alternative ACE inhibitor option 1

Second-Line Options

• Amitriptyline: Traditionally used but exercise caution in a 61-year-old due to anticholinergic effects (cognitive impairment, urinary retention, cardiac arrhythmia risk) 2, 4, 7
  • Despite concerns, amitriptyline becomes more commonly prescribed with increasing age and may be appropriate if first-line agents fail 7
• Flunarizine: Effective second-line option 2
• Valproate: Contraindicated if any childbearing potential remains 2

Third-Line: CGRP Monoclonal Antibodies

• Eptinezumab, erenumab, fremanezumab, galcanezumab 1, 2
• Newer guidelines position these as first-line in some countries, but access varies 8, 9
• Excellent safety profile in older adults - major advantage over traditional preventives 5
• In Europe, restricted to patients who failed other preventives 2

Atogepant (Oral Gepant)

• Approved for prevention with favorable tolerability 1

Special Considerations for Age 61

Critical Pitfalls to Avoid

1. Cardiovascular screening is mandatory before triptans - assess for coronary disease, stroke, peripheral arterial disease 4, 5
2. Avoid tricyclic antidepressants as first choice due to anticholinergic burden 4
3. Monitor kidney function - NSAIDs and many preventives require dose adjustment with declining renal function 3
4. Assess for polypharmacy - drug interactions increase with age 3
5. Rule out secondary headache - new-onset or changing migraine after age 50 warrants investigation for temporal arteritis, mass lesions, or other secondary causes 2, 4

Age-Specific Advantages of Newer Agents

The gepants (both acute and preventive) and CGRP monoclonal antibodies represent a significant advance for older adults because they:

• Lack cardiovascular contraindications 5, 3
• Have minimal drug interactions 5
• Demonstrate excellent tolerability 5
• Avoid cognitive and anticholinergic side effects 5

Non-Pharmacological Adjuncts

Consider adding 1, 2:

• Aerobic exercise or physical therapy - evidence-supported for both acute and preventive management
• Neuromodulatory devices - non-invasive options with minimal side effects
• Biobehavioral therapy - effective adjunct
• Acupuncture (though not superior to sham) 2

Avoid relying on spinal manipulation or dietary approaches - insufficient evidence 2.

Treatment Efficacy Assessment

• Evaluate response after 3 months of preventive therapy at therapeutic dose 9
• Goal: ≥50% reduction in monthly migraine days 9
• If inadequate response, switch to different first-line agent or advance to next tier 9